A Double Blind, Randomized Trial of Monthly Treatment

with Topical Metronidazole and Miconazole Co-Formulated Suppositories versus Placebo for Preventing Vaginal Infections in HIV-seronegative Women

Funding: NIH/STI CTG Protocol (09-0070)
PI: McClelland (Study Leader)
Time Period: 6/2009-11/2013

This four-site study (Mombasa, Nairobi X2, and Birmingham, Alabama) will test the efficacy of monthly periodic presumptive treatment with topical metronidazole and miconazole versus placebo for reducing the incidence of BV and VVC in HIV-1-seronegative women.

Comments are closed.